Interferon-beta: treatment option against COVID-19

Faiz Ul Haq; Muhammad Usman Khan; Ayesha Muazzam; Hajrah Farooq; Javeria Iqbal; Muhammad Imran; Rabia Bashir; Sania Ahmad; Sara Arif

doi:10.4081/gc.2020.9093

Perspective Articles Open access

Interferon-beta: treatment option against COVID-19

Authors

Faiz Ul Haq – articles in this journal Corresponding author Email http://orcid.org/0000-0002-9391-0032 Department of Microbiology University of Health Sciences Lahore; Center for Biotechnology and Microbiology University of Swat, Pakistan.
Muhammad Usman Khan – articles in this journal Department of Pharmacology University of Health Sciences Lahore, Pakistan.
Ayesha Muazzam – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.
Hajrah Farooq – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.
Javeria Iqbal – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.
Muhammad Imran – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.
Rabia Bashir – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.
Sania Ahmad – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.
Sara Arif – articles in this journal Department of Microbiology University of Health Sciences Lahore, Pakistan.

Published: 6 July 2020
Issue: Vol. 6 No. 3 (2020)
Section: Perspective Articles
DOI: 10.4081/gc.2020.9093

Abstract

In December 2019, an increasing number of cases of novel coronavirus (2019-nCoV) that were linked to seafood wholesale market have identified in Wuhan, China. Taxonomist declared 2019-nCoV as severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2) and the disease termed as COVID-19. Importantly, there is no approved drugs or vaccine against SARS-CoV-2. Current review is related to address treatment option for COVID-19. Interferon-β have shown significant activity against previous outbreak of SARS-CoV and MERS-CoV. Faced with an ongoing pandemic of SARS-CoV-2 and lack of effective treatment options, identifying compounds with antiviral activity has become a high priority. Efficacy of these treatments is still unclear. Therefore, final analysis is important to develop better treatment strategies for ongoing pandemic.

Keywords

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

PDF
HTML

Article history

Received: 8 May 2020
Accepted: 22 June 2020
Published: 6 July 2020

Article statistics

1,551abstract views

650PDF

48HTML

Smart Citations (scite.ai)

How to Cite

Ul Haq, F., Khan, M. U., Muazzam, A., Farooq, H., Iqbal, J., Imran, M., Bashir, R., Ahmad, S., & Arif, S. (2020). Interferon-beta: treatment option against COVID-19. Geriatric Care, 6(3). https://doi.org/10.4081/gc.2020.9093

Download Citation

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.